CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea

Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2015;21(4):358-364. Published online 2015 December 24 DOI: https://doi.org/10.3350/cmh.2015.21.4.358

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea

Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clinical and Molecular Hepatology. 2015;21(4):358

Link1 Link2

P148: Early virological response is a predictor of treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Journal of Viral Hepatitis. 2015;22:93-93

Link1

P0831 : Safety and efficacy of Sofosbuvir-based treatment regimens for chronic hepatitis C virus infection: A “Real-Life”, single-center experience in 117 patients

M.H. Wehmeyer, C. Eißing, S. Jordan, A.W. Lohse, J. Schulze zur Wiesch, S. Lüth

Journal of Hepatology. 2015;62:S649

Link1 Link2

Efficacy and safety of sofosbuvir-based therapy for the treatment of chronic hepatitis C in treatment-naïve and treatment-experienced patients

Xi Liu, Yawen Wang, Guanjun Zhang, Na Li, Qianqian Zhu, Hongyun Chang, Qunying Han, Yi Lv, Zhengwen Liu

International Journal of Antimicrobial Agents. 2014;44(2):145-151

Link1 Link2

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in HCV genotype IV infected patients

Bin-Qiao Wang, Yong-Lin Wang, Ke-Qing Shi

Liver International. 2016;37(5):765-765

Link1 Link2 Link3

Tu1500 – Single Center Experience with Sofosbuvir/Velpatasvir/Voxilaprevir (VOSEVI) Based Therapy for Chronic Hepatitis C Infection

Patrick Brown, Zachary Demertzis, Syed-Mohammed Jafri

Gastroenterology. 2019;156(6):S-1344

Link1 Link2

Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimen

Atsunori Kusakabe, Masayuki Kurosaki, Jun Itakura, Kouji Joko, Takehiro Akahane, Keiji Tsuji, Haruhiko Kobashi, Tetsuro Sohda, Hiroyuki Kimura, Ryouichi Narita, Koichirou Furuta, Namiki Izumi

Hepatology Research. 2019;

Link1 Link2

Sofosbuvir: A Review of its Use in Patients with Chronic Hepatitis C

Gillian M. Keating

Drugs. 2014;74(10):1127-1146

Link1

Link2 Link3

Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in Egypt

Ahmed Nagaty, Ekram W. Abd El-Wahab

PLOS ONE. 2017;12(10):e0184654

Link1

THU-113-Comparison between safety and efficacy of two treatment regimens for pediatric patients with chronic hepatitis C virus: Sofosbuvir/ledipasvir versus sofosbuvir/daclatasvir regimen

Mohamed Ahmed, Abdelfattah Hanno, Soraya Hamouda, Manal Abdelgawad, Hossam Abouelkhier

Journal of Hepatology. 2019;70(1):e208

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.